Join us for a critical conversation with leading expert Garo Armen, Chairman and CEO at Agenus, a revolutionary biotech company specializing in new immunotherapy treatments.

He will discuss the potential timing and effectiveness of therapeutic treatments for COVID-19, the prospects for a viable vaccine, and address what the retail industry needs to understand about how the virus is evolving.

During this session, the Shoptalk team will introduce a series of new scenarios through which the Shoptalk Retail Framework for COVID-19 can now be viewed. Shoptalk will assess how retail is set to change in (1) an Optimistic Scenario in which social distancing, testing and contact tracing prove effective, and in which therapeutic treatments and/or a vaccine become available sooner than expected, (2) a Pessimistic Scenario in which there is little progress in all of these areas, and (3) a Recurrence Scenario in which there are future waves of the virus.